Case control study of diffusion tensor imaging in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Case control study of diffusion tensor imaging in Parkinson's disease.

Case control study of diffusion tensor imaging in Parkinson's disease.

http://www.wikidata.org/entity/Q36172532

about

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects Microstructural changes in the substantia nigra of asymptomatic agricultural workers Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.MRI reveals brain abnormalities in drug-naive Parkinson's disease.A review of the use of magnetic resonance imaging in Parkinson's disease.Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease.Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson's Disease Dementia.Free-water imaging in Parkinson's disease and atypical parkinsonism.Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.New non-linear color look-up table for visualization of brain fractional anisotropy based on normative measurements - principals and first clinical use.Secondary signal change and an apparent diffusion coefficient decrease of the substantia nigra after striatal infarction.Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging.Why psychosis is frequently associated with Parkinson's disease?Magnetic resonance imaging of the substantia nigra in Parkinson's disease.Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results.Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism.Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.Imaging nigral pathology and clinical progression in Parkinson's disease.Putaminal Diffusivity Correlates With Disease Progression in Parkinson's Disease: Prospective 6-Year Study Thalamic projection fiber integrity in de novo Parkinson disease.White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson's disease.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.The search for biomarkers in Parkinson's disease: a critical review.White matter microstructural characteristics in newly diagnosed Parkinson's disease: An unbiased whole-brain study.9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.Development of Parkinson's disease biomarkers.Biomarkers of Parkinson's disease: current status and future perspectives.Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

P2860

Q22065275-0E8CF394-4BA0-41AC-BF03-DEF94DE8FDF5 Q24040262-1C92747D-407D-4AA4-A326-70938F6B535A Q28395854-B4DE1ABB-2BD1-42FB-80FF-E0D06D1ABE1A Q28396222-82C6B097-4542-465C-BC45-6B91EE5BB235 Q28397004-883A4687-F2F8-4F06-8212-A001449B118D Q28744585-A6353052-8379-43C1-A563-06BD3315F94F Q30583514-25625ED4-C9B4-49C9-AEE7-F13882BE4E46 Q30688718-3E9B4CA2-69AF-4D9B-879A-F418CFFEDC35 Q30835548-61816869-EA74-4BB9-AE9A-2495A29E5183 Q30873974-6F1DF316-7D8C-4AAB-9713-42824103B5C4 Q30906473-EED6A4FB-5088-48B7-A2A2-BE95501F42A6 Q31015635-2BFF875F-48EA-4C2F-9ABE-2DC1901B0531 Q31034031-C4F4EB64-98A3-41D6-B2F5-D63161D10021 Q31053308-91E3319A-AD4C-4139-867F-7646B079DA4F Q31131389-7EC40B0C-514E-489D-B9D2-02DE510BA824 Q33842249-09A088AB-9206-4540-BC9D-566B2CEBBC4A Q34014486-3EB39E80-C2A4-4ADD-BF9F-73871D1B181E Q34094668-7631E27F-38F9-4A64-8D29-EEF8F4D617BA Q34287154-C1057F3F-B522-4A00-850D-DE49207F922F Q34288372-2B03FF66-7A45-4D99-BDCE-CE2EF0C1458A Q34601225-AF8BD090-9474-4025-98D9-01F868099034 Q35159185-04D7358F-A949-4E7F-9C6E-BF15B458A340 Q35564787-8F64884D-EC3C-4F0A-8DE7-C97F94220783 Q35829608-A1441292-56C2-4645-99F9-9E3BDE5419F4 Q35880556-1CE65B34-A7FA-404E-9BF5-D32E626F655E Q36147414-79F55200-1FC1-4DBF-BE0B-75A54F418A66 Q36378779-BDD21F4D-6059-40E0-B014-B397A6F27014 Q36434577-1AD7DC55-3DEB-42F7-8B59-76EA13484B88 Q36580852-672C4448-1B0C-4508-91A8-47992CB36C96 Q36893101-806E7DB1-B535-41FE-AD3E-0DD0FB1744DA Q36916638-726738F4-268C-4593-90EC-846F4599028E Q37267022-EA85D8AF-51FC-416B-8F22-649A9E81CD7F Q37313955-35BD4B1C-7202-4363-BA6B-3F45C66EB7A9 Q37352054-7A42534D-9A71-4716-9CE4-42F6A79BA388 Q37352739-8BDB7DCC-A8A1-434D-9ECD-EDBCF0F6E41A Q37485071-F119CF3F-4BC1-41F8-A66A-417C58FCAD19 Q37691518-72A5F110-566C-402A-810A-BC54C964CE67 Q37810992-465639F8-142D-4E02-B46D-A7D15B787064 Q38043841-F261EC29-C30D-437A-9218-67EBCF9922BB Q38085592-792112B4-B4CB-43BB-97F2-7B4DFDC64AF2

P2860

Case control study of diffusion tensor imaging in Parkinson's disease.

http://www.wikidata.org/entity/Q36172532

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Case control study of diffusion tensor imaging in Parkinson's disease.

@ast

Case control study of diffusion tensor imaging in Parkinson's disease.

@en

type

label

Case control study of diffusion tensor imaging in Parkinson's disease.

@ast

Case control study of diffusion tensor imaging in Parkinson's disease.

@en

prefLabel

Case control study of diffusion tensor imaging in Parkinson's disease.

@ast

Case control study of diffusion tensor imaging in Parkinson's disease.

@en

P1433

Q36172532-4F9B6317-2700-4BE7-8A6C-5D53B9C0048E

P1476

Q36172532-F4B53C4D-2F03-48B4-AD6D-F987E253A3FF

P2093

Q36172532-10821713-3D3E-4E0F-B15B-2301BC099DE2

Q36172532-2647275A-9698-4741-B4F1-AC86B20E41DF

Q36172532-28E94DB1-19F4-49F2-A3AB-BF0E48963753

Q36172532-3521D84D-3574-4E60-BBDE-4E5A3F2C557E

Q36172532-365066AA-64BB-4E7B-B0E9-12FFB609E02E

Q36172532-3CE4391C-4CEA-4FDC-B22D-90F0B8E0C0A7

Q36172532-46CADA58-8F43-4001-92CB-F36FA90124BF

Q36172532-4E5F1BEA-7A88-4758-883A-AB7AAEC3F3F5

P2860

Q36172532-04BB5545-403E-4972-A8DD-6FC46B35F221

Q36172532-08836DE1-047D-465E-A8B4-5A04E303B4BB

Q36172532-0896C680-03DD-4DFF-85ED-397D61D92B64

Q36172532-0F4C77F8-8DCB-46C6-A6A9-0CBC3159FFB2

Q36172532-252E37EF-B90C-4CF6-8161-A97F78B01AC5

Q36172532-487D7084-9B85-406D-91FA-448458B21D9F

Q36172532-4FF54A11-BADC-4E91-ACE7-7760E8E605FE

Q36172532-56CF17C4-3D32-47BB-B340-11BB111476E4

Q36172532-5F2D2858-DBB5-46AE-9588-C7324B1C3BE8

Q36172532-6E8A065C-A379-4437-A8A3-A00750CCBB64

P304

Q36172532-89D38F5B-6007-48E9-9BEC-43383F9D766F

P31

Q36172532-89663B3F-2806-4DE3-96DF-C6BC75942BFB

Q36172532-e772d24e-e4c9-4b9e-b65f-fda1bd667cb3

P356

Q36172532-9C2DBEB3-9D56-4E69-B4BA-AC48B52396E6

P407

Q36172532-0B5880DB-A9CF-4864-8402-EE628329D19E

P433

Q36172532-D34C6266-4DB7-49D2-8815-419FCF98C811

P478

Q36172532-02CCE413-03C7-4AB7-B39E-0DD1D0FA07E6

P50

Q36172532-74B3335B-533D-44D9-9ECE-CD014A3B19F7

P577

Q36172532-55B2140C-C8E4-45D4-8E02-D2D255EF1609

P5875

Q36172532-52FFF8FF-2869-4BD5-B2F3-8173F3264BC6

P698

Q36172532-E474D99C-D48C-4C95-A961-9DB919D72946

P921

Q36172532-96F4FD40-03FA-4F4E-9CFA-B214CD129AF5

P932

Q36172532-A1C65944-3043-423B-9350-1C104A3A00A2

P356

JNNP.2007.121525

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Case control study of diffusion tensor imaging in Parkinson's disease

@en

P2093

E Lee

http://www.w3.org/2001/XMLSchema#string

E-K Tan

http://www.w3.org/2001/XMLSchema#string

G-L Ho

http://www.w3.org/2001/XMLSchema#string

H Rumpel

http://www.w3.org/2001/XMLSchema#string

H-V Loo

http://www.w3.org/2001/XMLSchema#string

K Yap

http://www.w3.org/2001/XMLSchema#string

S Fook-Chong

http://www.w3.org/2001/XMLSchema#string

Y Yuen

http://www.w3.org/2001/XMLSchema#string

P2860

Diffusion tensor MR imaging of the human brain

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

Parkinson's disease. First of two parts

Diffusion tensor imaging study of subcortical gray matter in cadasil.

Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis.

Use of functional imaging in Parkinsonism and dementia.

Characterization of central nervous system structures by magnetic resonance diffusion anisotropy.

Diffusion tensor imaging and aging.

Principles of diffusion tensor imaging and its applications to basic neuroscience research.

Looking into the functional architecture of the brain with diffusion MRI.

P304

1383-1386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.2007.121525

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6223096

http://www.w3.org/2001/XMLSchema#string

P698

17615165

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2095589

http://www.w3.org/2001/XMLSchema#string